Edwards Lifesciences – Mitral and Tricuspid Therapies at PCR London Valves 2021
Published: 27 November 2021
Edwards Lifesciences Mitral and Tricuspid Therapies at PCR London Valves 2021 – Introduction
Filmed around PCR London Valves 2021, this programme brings together three opinion leaders to discuss the latest in mitral and tricuspid therapies in the Edwards’ portfolio. Chair Prof Philipp Lurz (Heart Center Leipzig of University Leipzig, DE) is joined by Dr Sam Dawkins (John Radcliffe Hospital, Oxford, UK) and Prof Nicole Karam (Georges Pompidou European Hospital University of Paris, FR) to summarise the challenges facing MR and TR, and review latest data supporting strategies to achieve optimal patient outcomes.
More from this programme
Part 1 – Edwards Lifesciences Mitral and Tricuspid Therapies at PCR London Valves 2021 – Introduction
Part 2 – Seeing is Believing: Predictable and Durable Treatment of MR Across Etiologies With the PASCAL Platform
Part 3 – Edwards' Transcatheter Trilogy: An Exclusive Portfolio of Three Options to Treat TR
Prof Philipp Lurz is Deputy Head of the Department at Heart Center Leipzig, Germany, a position he has held since 2018. Previously, Prof Lurz was a Clinical Research Fellow at Great Ormond Street Hospital for Children NHS Foundation Trust. He completed his education at the University of Leipzig, and is a member of the German Society of Cardiology. Prof Lurz is widely published in leading international peer-reviewed journals.